Drone-based hyperspectral imaging platform that detects wheat scab (Fusarium head blight) symptoms across 1-40 acres per flight, using ensemble feature selection and deep learning to identify the most informative spectral bands for early, large-scale disease phenotyping in wheat breeding programs.
This solution applies drone-mounted hyperspectral imaging to detect wheat scab (Fusarium head blight, FHB) symptoms at field scale, enabling breeders and crop researchers to phenotype disease response across 1-40 acres per flight. By combining narrow-band spectral feature selection with deep learning models, the platform targets specific wavebands that carry the most diagnostic information, supporting earlier and more accurate disease detection than visual scouting or conventional RGB imagery. The approach is designed to accelerate wheat breeding for scab resistance by delivering high-throughput, objective, and repeatable disease severity measurements across large breeding nurseries.
The underlying spectral feature selection and deep learning algorithms have been validated in prior lab-based and field-based studies for related crop sensing tasks, including controlled-environment early wheat scab detection. The drone hyperspectral deployment for large-scale FHB severity assessment is at the field validation stage, with planned trials across diverse wheat genotypes at St. Paul and Crookston, Minnesota, using over 600 plots per location and imaging at multiple time points after inoculation to train and benchmark detection models.
The University of Minnesota is a flagship, comprehensive public research university spanning multiple campuses, with a large research enterprise and clinical integration. Industry engages through co-located labs on the Twin Cities campuses, access to an academic health system for clinical translation, and pilot and field-testing facilities that speed scale-up. A statewide extension network and outreach centers provide real-world sites and data partnerships across Minnesota, while proximity to a dense medtech and Fortune 500 corridor enables frequent collaboration. Research is supported by competitive federal funding, including NIH, NSF, DOE, USDA, and DoD. A dedicated technology transfer office manages IP, licensing, sponsored research agreements, and startup incubation to speed commercialization.